Shanghai Visonpharma patents agents for treating hepatitis B virus infections July 6, 2022 No Comments
Janssen, Johnson & Johnson present new compounds for the treatment of hepatitis B July 5, 2022 No Comments
Polysaccharide-protein antigen pneumococcal vaccine effective in type 3 invasive disease model July 4, 2022 No Comments
New antibacterials described by the Centre National de la Recherche Scientifique (CNRS) July 4, 2022 No Comments
Ainos reports preclinical data on low-dose oral interferon-alpha Veldona against COVID-19 June 28, 2022 No Comments
Brilacidin inhibits Omicron, Delta, Gamma and Alpha SARS-CoV-2 variants in vitro June 27, 2022 No Comments
RSS